Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery
NCT06674252Phase 2Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jun 2025
- Primary completion
- Sep 2027
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of bufei decoction in lung cancer, sponsored by Peking University Cancer Hospital & Institute. Started Jun 2025; status: recruiting.
02
Drugs
bufei decoction
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT06674252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06674252.